These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9839590)
1. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma. Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590 [TBL] [Abstract][Full Text] [Related]
2. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma]. Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140 [TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848 [TBL] [Abstract][Full Text] [Related]
5. The clinical implications of telomerase activity in upper tract urothelial cancer and washings. Wu WJ; Liu LT; Huang CN; Huang CH; Chang LL BJU Int; 2000 Aug; 86(3):213-9. PubMed ID: 10930917 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of bladder cancer using telomerase activity in voided urine. Cheng CW; Chueh SC; Chern HD J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745 [TBL] [Abstract][Full Text] [Related]
7. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104 [TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Yoshida K; Sugino T; Tahara H; Woodman A; Bolodeoku J; Nargund V; Fellows G; Goodison S; Tahara E; Tarin D Cancer; 1997 Jan; 79(2):362-9. PubMed ID: 9010110 [TBL] [Abstract][Full Text] [Related]
9. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma. Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490 [TBL] [Abstract][Full Text] [Related]
10. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer. Isurugi K; Suzuki Y; Tanji S; Fujioka T J Urol; 2002 Oct; 168(4 Pt 1):1574-7. PubMed ID: 12352460 [TBL] [Abstract][Full Text] [Related]
11. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia. Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; Ando K; Aizawa T; Ito T; Miki M; Ebihara Y Cancer; 1998 Dec; 83(12):2554-60. PubMed ID: 9874463 [TBL] [Abstract][Full Text] [Related]
12. A study comparing various noninvasive methods of detecting bladder cancer in urine. Saad A; Hanbury DC; McNicholas TA; Boustead GB; Morgan S; Woodman AC BJU Int; 2002 Mar; 89(4):369-73. PubMed ID: 11872026 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of urinary molecular markers in bladder cancer. Eissa S; Swellam M; el-Mosallamy H; Mourad MS; Hamdy NΜ; Kamel K; Zaglol AS; Khafagy MM; el-Ahmady O Anticancer Res; 2003; 23(5b):4347-55. PubMed ID: 14666650 [TBL] [Abstract][Full Text] [Related]
14. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723 [TBL] [Abstract][Full Text] [Related]
16. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519 [TBL] [Abstract][Full Text] [Related]
18. Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: Causative factors affecting sensitivity and specificity. Akao T; Kakehi Y; Wu XX; Kinoshita H; Takahashi T; Ogawa O; Kato T; Yoshida O Urol Oncol; 1997; 3(4):118-24. PubMed ID: 21227116 [TBL] [Abstract][Full Text] [Related]
19. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530 [TBL] [Abstract][Full Text] [Related]
20. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma. Bian W; Xu Z Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]